Closed System Transfer Device Market Size, Share By Type (Needleless Systems and Membrane-to-Membrane Systems), By Closing Mechanism (Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, and Luer-Lock Systems), By Component (Syringe Safety Devices, Vial Access Devices, Accessories, and Bag/Line Access Devices), By End User (Clinics & Oncology Centers, Hospitals, and Others) - Global Industry Analysis, Growth, Trends Analysis, Segment Forecasts, Regional Outlook 2020 - 2027


In 2019, the global closed system transfer device market size was valued at USD 380 million and is predicted to reach USD 1,620.6 million by 2027, with a CAGR of 20.6% from 2020 to 2027.

Closed System Transfer Device Market Size 2016 to 2027

Key market Insights:

The requirement for (CSTDs) closed system transfer devices is increasing rapidly, due to the increasing occurrence of cancer, rising implementation of CSTDs for transporting hazardous medications, such as cytotoxic or antineoplastic drugs, the increasing need for monitoring compliance for safe management of injurious drugs, and escalating quantity of drug sanctions for cancer. These are some key factors driving the global closed system transfer device market. Moreover, closed system transfer devices support in circumventing environmental contamination with damaging drugs resulting in augmented device adoption, that in turn, drives the market development. The use of closed system transfer devices for other healing applications and quick use of CSTDs in developing markets are projected to generate new growth opportunities for the worldwide closed system transfer device market.

Crucial factors accountable for market growth are:

  • Increasing prevalence of cancer
  • Growing need for regulatory compliance for safe handling of harmful drugs
  • Rising adoption of closed system transfer devices for transferring hazardous drugs
  • Increasing use of CSTDs in emerging markets

Significant Market Trends:

Membrane-to-Membrane Systems Segment Seized Foremost Market Stake in 2019

Membrane-to-Membrane Systems segment recorded the prime market share in the global closed system transfer device Market in 2019. The membrane-to-membrane transference devices use the dual membrane system among the syringe and vial further supports to isolate the medical preparation. The factors such as reduced contamination risk, and ease of usage of the double-membrane systems confirm the safety expected to increase the usage of the membrane-to-membrane transmission devices over the estimate period.

The needleless systems are projected grow at the highest CAGR during the forecast period mainly due to benefits such as needle-free transmission of the drugs. Moreover, new product launches are expected to contribute in high growth of needleless systems.

Push-To-Turn Systems Projected to Rulethe Closing Mechanism Segment of Closed System Transfer Device Market Revenue

Closed system transfer devices are rapidly being employed for the safe transfer of harmful medical preparations. High research and development activity in closed system transfer device for the transfer of oncology medications is the major reason for the high revenue share of closed system transfer devices.

Luer-lock systems segment will expand at the highest CAGR during the forecast time-frame.

Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue

Hospitals have the funds to procure expensive closed system transfer devices that help in safe transfer of hazardous medical preparations when compared to small clinics and oncology centres.

North America is Estimated to be the Largest Market for Closed System Transfer Device

The research report covers key trends and prospects of closed system transfer device products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, closed system transfer device market is conquered by North America owing to high incidence of cancer and presence of sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufactures to launch new products.

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global closed system transfer device market. Leading competitors contending in global closed system transfer device market are as follows:

  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • CodanMedizinischeGeräte GmbH & Co Kg
  • ICU Medical, Inc.
  • Yukon Medical
  • Braun Melsungen
  • Equashield
  • Teva Pharmaceutical Industries Ltd.
  • Victus, Inc.
  • Corvida Medical

In order to better recognize the current status of closed system transfer device, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the closed system transfer device market. This research study bids qualitative and quantitative insights on closed system transfer device market and assessment of market size and growth trend for potential market segments.

Report Scope of the Clinical Trials Market

Report Highlights Details
Market Size USD 1620.6 Million by 2027
Growth Rate CAGR of 20.6% from 2021 to 2027
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2027
Segments Covered Type, Component, End User, Closing Mechanism, Region
Companies Mentioned Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical

 

Major Market Segments Covered:

By Type

  • Needleless Systems
  • Membrane-to-Membrane Systems

By Closing Mechanism

  • Color-To-Color Alignment Systems
  • Push-To-Turn Systems
  • Click-To-Lock Systems
  • Luer-Lock Systems

By Component

  • Syringe Safety Devices
  • Vial Access Devices
  • Accessories
  • Bag/Line Access Devices

By End User

  • Clinics & Oncology Centers
  • Hospitals
  • Others

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa
Request for Customize Report
Precedence offers custom market research services that help clients to get information on their business scenario required.

Frequently Asked Questions

What is the current size of the global closed system transfer device market?
According to Precedence Research, the global closed system transfer device market size stood at USD 380 million in 2019 and is predicted to reach USD 1,620 million by the end of 2027.
The global closed system transfer device market is growing at a CAGR of 20.6% during the forecast period 2020 to 2027.
Factors such as growing prevalence of cancer and rising need for monitoring compliance for harmless handling of damaging drugs are driving the growth of closed system transfer device market.
In 2019, North America dominated the global market with a market share of more than 42%.
Asia Pacific is anticipated to grow at the maximum CAGR of around 18% in the forecast period due to high incidence of cancer.
The major companies operating in the worldwide closed system transfer device are Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical among others.
Push-To-Turn systems projected to rule the closing mechanism segment of closed system transfer device market revenue.
Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client

Get a Sample